These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 12962719
1. Minor histocompatibility antigens in human stem cell transplantation. Falkenburg JH, van de Corput L, Marijt EW, Willemze R. Exp Hematol; 2003 Sep; 31(9):743-51. PubMed ID: 12962719 [Abstract] [Full Text] [Related]
2. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity. Stumpf AN, van der Meijden ED, van Bergen CA, Willemze R, Falkenburg JH, Griffioen M. Blood; 2009 Oct 22; 114(17):3684-92. PubMed ID: 19706888 [Abstract] [Full Text] [Related]
4. [Target antigens for graft-versus-host disease (GVHD) and graft-versus-leukemia/tumor (GVL/T)]. Tanaka J. Nihon Rinsho; 2003 Sep 22; 61(9):1512-9. PubMed ID: 14515717 [Abstract] [Full Text] [Related]
5. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II. van Balen P, van Bergen CAM, van Luxemburg-Heijs SAP, de Klerk W, van Egmond EHM, Veld SAJ, Halkes CJM, Zwaginga JJ, Griffioen M, Jedema I, Falkenburg JHF. Front Immunol; 2018 Sep 22; 9():3016. PubMed ID: 30619360 [Abstract] [Full Text] [Related]
8. Minor histocompatibility antigens as targets of graft-versus-leukemia reactions. Falkenburg JH, Marijt WA, Heemskerk MH, Willemze R. Curr Opin Hematol; 2002 Nov 22; 9(6):497-502. PubMed ID: 12394171 [Abstract] [Full Text] [Related]
9. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Fowler DH, Gress RE. Leuk Lymphoma; 2000 Jul 22; 38(3-4):221-34. PubMed ID: 10830730 [Abstract] [Full Text] [Related]
16. The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond. Tsirigotis P, Shimoni A, Nagler A. Ann Med; 2014 Sep 22; 46(6):384-96. PubMed ID: 24888385 [Abstract] [Full Text] [Related]
18. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction. van der Zouwen B, Kruisselbrink AB, Frederik Falkenburg JH, Jedema I. Biol Blood Marrow Transplant; 2014 Jun 22; 20(6):760-9. PubMed ID: 24607556 [Abstract] [Full Text] [Related]
19. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation]. Hudecek M, Bartsch K, Tschiedel S, Niederwieser D. Dtsch Med Wochenschr; 2008 Jul 22; 133(28-29):1511-6. PubMed ID: 18597211 [Abstract] [Full Text] [Related]
20. Mechanisms of minor histocompatibility antigen immunogenicity: the role of infinitesimal versus structurally profound polymorphisms. Brickner AG. Immunol Res; 2006 Jul 22; 36(1-3):33-41. PubMed ID: 17337764 [Abstract] [Full Text] [Related] Page: [Next] [New Search]